vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Mobileye Global Inc. (MBLY). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $558.0M, roughly 1.5× Mobileye Global Inc.). On growth, Mobileye Global Inc. posted the faster year-over-year revenue change (27.4% vs 7.5%). Over the past eight quarters, Mobileye Global Inc.'s revenue compounded faster (12.7% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Mobileye Global Inc. is a United States-domiciled, Israel-headquartered autonomous driving company. It is developing self-driving technologies and advanced driver-assistance systems (ADAS) including cameras, computer chips, and software. Mobileye was acquired by Intel in 2017 and went public again in 2022.
ACHC vs MBLY — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $558.0M |
| Net Profit | $4.5M | — |
| Gross Margin | — | 49.3% |
| Operating Margin | — | -647.5% |
| Net Margin | 0.5% | — |
| Revenue YoY | 7.5% | 27.4% |
| Net Profit YoY | -50.8% | — |
| EPS (diluted) | $0.05 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | $558.0M | ||
| Q4 25 | $821.5M | $446.0M | ||
| Q3 25 | $851.6M | $504.0M | ||
| Q2 25 | $869.2M | $506.0M | ||
| Q1 25 | $770.5M | $438.0M | ||
| Q4 24 | $774.2M | $490.0M | ||
| Q3 24 | $815.6M | $486.0M | ||
| Q2 24 | $796.0M | $439.0M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $-127.0M | ||
| Q3 25 | $36.2M | $-96.0M | ||
| Q2 25 | $30.1M | $-67.0M | ||
| Q1 25 | $8.4M | $-102.0M | ||
| Q4 24 | $32.6M | $-71.0M | ||
| Q3 24 | $68.1M | $-2.7B | ||
| Q2 24 | $78.5M | $-86.0M |
| Q1 26 | — | 49.3% | ||
| Q4 25 | — | 45.3% | ||
| Q3 25 | — | 48.2% | ||
| Q2 25 | — | 49.8% | ||
| Q1 25 | — | 47.3% | ||
| Q4 24 | — | 49.2% | ||
| Q3 24 | — | 48.8% | ||
| Q2 24 | — | 47.6% |
| Q1 26 | — | -647.5% | ||
| Q4 25 | -142.4% | -31.4% | ||
| Q3 25 | 4.7% | -21.6% | ||
| Q2 25 | 5.8% | -14.6% | ||
| Q1 25 | 1.7% | -26.7% | ||
| Q4 24 | 4.9% | -17.6% | ||
| Q3 24 | 12.1% | -577.6% | ||
| Q2 24 | 13.4% | -21.4% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | -28.5% | ||
| Q3 25 | 4.3% | -19.0% | ||
| Q2 25 | 3.5% | -13.2% | ||
| Q1 25 | 1.1% | -23.3% | ||
| Q4 24 | 4.2% | -14.5% | ||
| Q3 24 | 8.4% | -558.6% | ||
| Q2 24 | 9.9% | -19.6% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $-0.15 | ||
| Q3 25 | $0.40 | $-0.12 | ||
| Q2 25 | $0.33 | $-0.08 | ||
| Q1 25 | $0.09 | $-0.13 | ||
| Q4 24 | $0.36 | $-0.09 | ||
| Q3 24 | $0.74 | $-3.35 | ||
| Q2 24 | $0.85 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $1.2B |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $8.2B |
| Total Assets | $5.5B | $8.7B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | $1.2B | ||
| Q4 25 | $133.2M | $1.8B | ||
| Q3 25 | $118.7M | $1.7B | ||
| Q2 25 | $131.4M | $1.7B | ||
| Q1 25 | $91.2M | $1.5B | ||
| Q4 24 | $76.3M | $1.4B | ||
| Q3 24 | $82.1M | $1.3B | ||
| Q2 24 | $77.2M | $1.2B |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | $8.2B | ||
| Q4 25 | $1.9B | $11.9B | ||
| Q3 25 | $3.1B | $11.9B | ||
| Q2 25 | $3.1B | $12.1B | ||
| Q1 25 | $3.0B | $12.0B | ||
| Q4 24 | $3.1B | $12.1B | ||
| Q3 24 | $3.0B | $12.1B | ||
| Q2 24 | $3.0B | $14.7B |
| Q1 26 | $5.5B | $8.7B | ||
| Q4 25 | $5.5B | $12.5B | ||
| Q3 25 | $6.4B | $12.5B | ||
| Q2 25 | $6.3B | $12.6B | ||
| Q1 25 | $6.1B | $12.5B | ||
| Q4 24 | $6.0B | $12.6B | ||
| Q3 24 | $5.9B | $12.6B | ||
| Q2 24 | $5.7B | $15.3B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $75.0M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | $75.0M | ||
| Q4 25 | $-86.3M | $113.0M | ||
| Q3 25 | $73.2M | $167.0M | ||
| Q2 25 | $133.5M | $213.0M | ||
| Q1 25 | $11.5M | $109.0M | ||
| Q4 24 | $116.7M | $204.0M | ||
| Q3 24 | $163.1M | $126.0M | ||
| Q2 24 | $171.1M | $30.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $86.0M | ||
| Q3 25 | $-63.0M | $143.0M | ||
| Q2 25 | $-34.2M | $199.0M | ||
| Q1 25 | $-163.2M | $95.0M | ||
| Q4 24 | $-86.8M | $191.0M | ||
| Q3 24 | $-27.1M | $104.0M | ||
| Q2 24 | $16.9M | $6.0M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 19.3% | ||
| Q3 25 | -7.4% | 28.4% | ||
| Q2 25 | -3.9% | 39.3% | ||
| Q1 25 | -21.2% | 21.7% | ||
| Q4 24 | -11.2% | 39.0% | ||
| Q3 24 | -3.3% | 21.4% | ||
| Q2 24 | 2.1% | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 6.1% | ||
| Q3 25 | 16.0% | 4.8% | ||
| Q2 25 | 19.3% | 2.8% | ||
| Q1 25 | 22.7% | 3.2% | ||
| Q4 24 | 26.3% | 2.7% | ||
| Q3 24 | 23.3% | 4.5% | ||
| Q2 24 | 19.4% | 5.5% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
MBLY
Segment breakdown not available.
